Publications
All publications
Carleton N, Chang AC, Lee S, et al. Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women. Nature Aging, 2026.
Hu M, Weldy A, Lovalvo IM, Akins EA, Jain S, Chang A, et al. Druggable genome CRISPRi screen in hydrogels reveals regulators of cortactin-driven actin remodeling promoting glioblastoma invasion. JCI Insight, 2026.
Onkar S, Liu D, Seachrist D, Zou J, Merkel C, Thale I, Chang A, et al. Novel transplantable mouse cell line model recapitulates invasive lobular breast carcinoma (ILC) phenotype and immune microenvironment. bioRxiv, 2026.
Carleton N, Chang AC, Chen F, et al. Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies. Clinical Cancer Research, 2026.
Chang HC, Shi Y, Cheng H, Zou J, Chang AC, et al. Benchmarking scRNA-seq Copy Number Inference: A Comprehensive Evaluation and Practitioner's Guide. bioRxiv, 2026.
Gu Y, Zuo D, Hu QX, Sanguin-Gendreau V, Pacis A, Guiot MC, Chang AC, et al. Activating mutations in ESR1 contribute to an immunosuppressive breast tumor microenvironment by dampening cytokine secretion. JCI Insight, 2026.
Zels G*, Van Baelen K*, Chang AC*, et al. Clinical and histopathological characterization of metastatic lobular breast cancer: lessons learned from post-mortem tissue donation programs. npj Breast Cancer, 2026.
Chang ACC, Hale E, Foldi J. Abemaciclib-Associated Psychosis: A Case Report of a Rare Neuropsychiatric Adverse Effect during Breast Cancer Treatment. Case Reports in Oncology, 2026.
Rajendran S, Chih-Chieh Chang A, Gao V, et al. Prescribing patterns and real-world clinical usage of adjuvant abemaciclib for early-stage, high-risk, hormone receptor-positive breast cancer. JCO Oncology Advances, 2026.
Chang AC, Balic M, Bartholow T, et al. Hope for OTHERS (Our Tissue Helping Enhance Research & Science): research results from the University of Pittsburgh rapid autopsy program for breast cancer. Breast Cancer Research, 2025.
Chang A, Schlegel B, Carleton N, McAuliffe P, Waltermire H, Oesterreich S, Schwartz R, Lee A. CITEgeist: Accurate deconvolution of spatial transcriptomics with same-slide proteomics reveals midkine as a secreted microenvironment modulator in ESR1 mutant breast cancer. bioRxiv, 2025.
Title follows the CV (newer than the v1 title indexed in PubMed).
Wang Y, Ruan L, Zhu J, Zhang X, Chang AC, Tomaszewski A, Li R. Metabolic regulation of misfolded protein import into mitochondria. eLife, 2024.
Jain S, Rick JW, Joshi RS, Beniwal A, Spatz J, Gill S, Chang AC, et al. Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects. Journal of Clinical Investigation, 2023.
Lau D, Wadhwa H, Sudhir S, Chang AC*, et al. Role of c-Met/β1 integrin complex in the metastatic cascade in breast cancer. JCI Insight, 2021.
Ruan L, McNamara JT, Zhang X, Chang AC, Zhu J, Dong Y, Sun G, Peterson A, Na CH, Li R. Solid-phase inclusion as a mechanism for regulating unfolded proteins in the mitochondrial matrix. Science Advances, 2020.
Feliciano J, Chang A, Venkatraman D, Brooks S, Zagaja C, Ettinger D, Hann C, Naidoo J, Voong R, Hales R, Turner M, Peterson V, Bodurtha J. Lung cancer and family-centered concerns. Supportive Care in Cancer, 2020.